OMAR BARI: Open Payments
NPI 1467958785 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,897 in 29 payments from 10 companies in 2025. Trend: 2023 $518 · 2024 $725 · 2025 $5,897
Speaker / faculty: $4,500Food & beverage: $1,351Travel & lodging: $36Education: $10
| Company | Payments | Amount |
|---|---|---|
| Verrica Pharmaceuticals Inc. | 10 | $4,916 |
| Galderma Laboratories, L.P. | 7 | $307 |
| Arcutis Biotherapeutics, Inc. | 3 | $146 |
| Janssen Scientific Affairs, LLC | 1 | $141 |
| ABBVIE INC. | 2 | $136 |
| GENZYME CORPORATION | 2 | $123 |
| Incyte Corporation | 1 | $42 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Lilly USA, LLC | 1 | $29 |
| LEO Pharma Inc. | 1 | $23 |
Products named: YCANTH, NEMLUVIO, Zoryve, TREMFYA, BOTOX, DUPIXENT, OPZELURA, Rhapsido.
Industry payments across OK — which companies pay providers there.
